Veritti D, Sarao V, Missiroli F, Ricci F, Lanzetta P (2019) Twelve-month outcomes of intravitreal aflibercept for neovascular age-related macular degeneration. Retina 39(11):2077–2083

Article  PubMed  CAS  Google Scholar 

Veritti D, Sarao V, Soppelsa V, Lanzetta P (2021) Managing diabetic macular edema in clinical practice: systematic review and meta-analysis of current strategies and treatment options. Clin Ophthalmol 15:375–385

Article  PubMed  PubMed Central  Google Scholar 

Fiore T, De Santi N, Pietrella D, Barcaccia M, Palmieri MI, Lupidi M et al (2024) Mobile unidirectional airflow device reduces air contamination in an intravitreal outpatient clean room setting. Int Ophthalmol 45(1):8

Article  PubMed  Google Scholar 

Ghasemi Falavarjani K, Nguyen QD (2013) Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature. Eye 27(7):787–794

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lai TYY, Liu S, Das S, Lam DSC (2015) Intravitreal injection—technique and safety. Asia-Pac J Ophthalmol 4(6):321–328

Article  CAS  Google Scholar 

Li AL, Wykoff CC, Wang R, Chen E, Benz MS, Fish RH et al (2016) Endophthalmitis after intravitreal injection. Retina 36(7):1349–1356

Article  PubMed  CAS  Google Scholar 

Hunyor AP, Merani R, Darbar A, Korobelnik J, Lanzetta P, Okada AA (2018) Topical antibiotics and intravitreal injections. Acta Ophthalmol 96(5):435–441

Article  PubMed  Google Scholar 

https://www.escrs.org/media/uljgvpn1/english_2018_updated.pdf

Choi W, Park SE, Kang HG, Byeon SH, Kim SS, Koh HJ et al (2019) Intraocular pressure change after injection of intravitreal dexamethasone (Ozurdex) implant in Korean patients. Br J Ophthalmol 103(10):1380–1387

Article  PubMed  Google Scholar 

Su L, Li H, Mou B, Liu K, Xu X (2024) Intravitreal injection practice patterns among Chinese ophthalmologists. Int J Ophthalmol 17(9):1717–1722

Article  PubMed  PubMed Central  Google Scholar 

Furino C, Grassi MO, Bini V, Nacucchi A, Boscia F, Reibaldi M et al (2020) Intravitreal injections in arc sterile setting: safety profile after more than 10,000 treatments. J Ophthalmol 15(2020):1–5

Article  Google Scholar 

Meredith TA, McCannel CA, Barr C, Doft BH, Peskin E, Maguire MG et al (2015) Postinjection endophthalmitis in the comparison of age-related macular degeneration treatments trials (CATT). Ophthalmology 122(4):817–821

Article  PubMed  Google Scholar 

Pilli S, Kotsolis A, Spaide RF, Slakter J, Freund KB, Sorenson J et al (2008) Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting. Am J Ophthalmol 145(5):879–882

Article  PubMed  CAS  Google Scholar 

Cheung CSY, Wong AWT, Lui A, Kertes PJ, Devenyi RG, Lam WC (2012) Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections. Ophthalmology 119(8):1609–1614

Article  PubMed  Google Scholar 

https://www.amedeolucente.it/public/LINEE%20GUIDA%20SOI%20INTRAVITREALI%207-FEBBRAIO-2021.pdf

ISPESL: Istituto Superiore per la Prevenzione e la Sicurezza del Lavoro. http://www.ispesl.it/documentazione/comp_sett.asp. 2009. Linee guida per la definizione degli standard di sicurezza e di igiene ambientale dei reparti operatori

Dossarps D, Bron AM, Koehrer P, Aho-Glélé LS, Creuzot-Garcher C, Berthon L et al (2015) Endophthalmitis after intravitreal injections: incidence, presentation, management, and visual outcome. Am J Ophthalmol 160(1):17-25.e1

Article  PubMed  Google Scholar 

Kiss S, Dugel P, Khanani A, Broder M, Chang E, Sun G et al (2018) Endophthalmitis rates among patients receiving intravitreal anti-VEGF injections: a USA claims analysis. Clin Ophthalmol 12:1625–1635

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chen Y, Wei W, Vavvas DG, Zhang F, She H, Zhou H et al (2020) Incidence of endophthalmitis after intravitreal anti-vascular endothelial growth factor injections in an operating room in China. J Ophthalmol 12:1–6

CAS  Google Scholar 

Tabandeh H, Boscia F, Sborgia A, Ciracì L, Dayani P, Mariotti C et al (2014) Endophthalmitis associated with intravitreal injections. Retina 34(1):18–23

Article  PubMed  Google Scholar 

Abell RG, Kerr NM, Allen P, Vote BJ (2012) Intravitreal injections: is there benefit for a theatre setting? Br J Ophthalmol 96(12):1474–1478

Article  PubMed  Google Scholar 

Freiberg FJ, Brynskov T, Munk MR, Sørensen TL, Wolf S, Wirth MA et al (2017) Low endophthalmitis rates after intravitreal anti-vascular endothelial growth factor injections in an operation room. Retina 37(12):2341–2346

Article  PubMed  CAS  Google Scholar 

Mishra C, Lalitha P, Rameshkumar G, Agrawal R, Balne PK, Iswarya M et al (2018) Incidence of endophthalmitis after intravitreal injections: risk factors, microbiology profile, and clinical outcomes. Ocul Immunol Inflamm 13:1–10

Article  Google Scholar 

Pacella E, Loffredo L, Malvasi M, Trovato Battagliola E, Messineo D, Pacella F et al (2020) Effects of repeated intravitreal injections of dexamethasone implants on intraocular pressure: a 4-year study. Clin Ophthalmol 14:3611–3617

Article  PubMed  PubMed Central  CAS  Google Scholar 

Proença Pina J, Turki K, Labreuche J, Duhamel A, Tran THC (2016) Efficacy and safety in retinal vein occlusion treated with at least three consecutive intravitreal dexamethasone implants. J Ophthalmol 2016:1–6

Article  Google Scholar 

Tservakis I, Koutsandrea C, Papaconstantinou D, Paraskevopoulos T, Georgalas I (2015) Safety and efficacy of dexamethasone intravitreal implant (Ozurdex) for the treatment of persistent macular edema secondary to retinal vein occlusion in eyes previously treated with anti-vascular endothelial growth factors. Curr Drug Saf 10(2):145–151

Article  PubMed  CAS  Google Scholar 

Malclès A, Dot C, Voirin N, Vié AL, Agard É, Bellocq D et al (2017) Safety of intravitreal dexamethasone implant (Ozurdex). Retina 37(7):1352–1359

Article  PubMed  Google Scholar 

Rezkallah A, Mathis T, Abukhashabah A, Voirin N, Malclès A, Agard É et al (2021) Long-term incidence and risk factors of ocular hypertension following dexamethasone-implant injections. Retina 41(7):1438–1445

Article  PubMed  CAS  Google Scholar